These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11273212)

  • 1. Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
    Depairon M; Chessex S; Sudre P; Rodondi N; Doser N; Chave JP; Riesen W; Nicod P; Darioli R; Telenti A; Mooser V;
    AIDS; 2001 Feb; 15(3):329-34. PubMed ID: 11273212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carotid artery intima-media thickness and HIV infection: traditional risk factors overshadow impact of protease inhibitor exposure.
    Currier JS; Kendall MA; Zackin R; Henry WK; Alston-Smith B; Torriani FJ; Schouten J; Mickelberg K; Li Y; Hodis HN;
    AIDS; 2005 Jun; 19(9):927-33. PubMed ID: 15905673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-density lipoprotein subfractions as markers of early atherosclerosis. PCVMETRA Group. Prévention Cardio-Vasculaire en Medecene du Travail.
    Atger V; Giral P; Simon A; Cambillau M; Levenson J; Gariepy J; Megnien JL; Moatti N
    Am J Cardiol; 1995 Jan; 75(2):127-31. PubMed ID: 7810486
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of atherosclerosis using carotid ultrasonography in a cohort of HIV-positive patients treated with protease inhibitors.
    Seminari E; Pan A; Voltini G; Carnevale G; Maserati R; Minoli L; Meneghetti G; Tinelli C; Testa S
    Atherosclerosis; 2002 Jun; 162(2):433-8. PubMed ID: 11996964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Frequency of Subclinical Atherosclerosis in Brazilian HIV-Infected Patients.
    Salmazo PS; Bazan SGZ; Shiraishi FG; Bazan R; Okoshi K; Hueb JC
    Arq Bras Cardiol; 2018 May; 110(5):402-410. PubMed ID: 29641646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fibrinogen and silent atherosclerosis in subjects with cardiovascular risk factors.
    Levenson J; Giral P; Razavian M; Gariepy J; Simon A
    Arterioscler Thromb Vasc Biol; 1995 Sep; 15(9):1263-8. PubMed ID: 7670937
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of protease inhibitor substitution with efavirenz in HIV-infected children: results of the First Pediatric Switch Study.
    McComsey G; Bhumbra N; Ma JF; Rathore M; Alvarez A;
    Pediatrics; 2003 Mar; 111(3):e275-81. PubMed ID: 12612284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma Low-Density Lipoprotein Cholesterol/High-Density Lipoprotein Cholesterol Concentration Ratio and Early Marker of Carotid Artery Atherosclerosis.
    Nimkuntod P; Tongdee P
    J Med Assoc Thai; 2015 May; 98 Suppl 4():S58-63. PubMed ID: 26201135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.
    Currier JS; Kendall MA; Henry WK; Alston-Smith B; Torriani FJ; Tebas P; Li Y; Hodis HN
    AIDS; 2007 May; 21(9):1137-45. PubMed ID: 17502724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
    Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Premature lesions of the carotid vessels in HIV-1-infected patients treated with protease inhibitors.
    Maggi P; Serio G; Epifani G; Fiorentino G; Saracino A; Fico C; Perilli F; Lillo A; Ferraro S; Gargiulo M; Chirianni A; Angarano G; Regina G; Pastore G
    AIDS; 2000 Nov; 14(16):F123-8. PubMed ID: 11101050
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Carotid plaque, aging, and risk factors. A study of 457 subjects.
    Fabris F; Zanocchi M; Bo M; Fonte G; Poli L; Bergoglio I; Ferrario E; Pernigotti L
    Stroke; 1994 Jun; 25(6):1133-40. PubMed ID: 8202970
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and determinants of carotid atherosclerosis in healthy postmenopausal women.
    Lassila HC; Tyrrell KS; Matthews KA; Wolfson SK; Kuller LH
    Stroke; 1997 Mar; 28(3):513-7. PubMed ID: 9056604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Subclinical carotid atherosclerosis and cardiovascular risk factors in HIV-infected patients.
    Kwiatkowska W; Knysz B; Drelichowska-Durawa J; Czarnecki M; Gąsiorowski J; Biłyk E; Karczewski M; Witkiewicz W
    Postepy Hig Med Dosw (Online); 2011 Nov; 65():770-83. PubMed ID: 22173442
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Surrogate markers for atherosclerosis in overweight subjects with atherogenic dyslipidemia: the GEMS project.
    Genoud M; Wietlisbach V; Feihl F; Mermod A; Morin D; Darioli R; Nicod P; Mooser V; Waeber B; Hayoz D; Waeber G
    Angiology; 2008; 59(4):484-92. PubMed ID: 18388087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence of carotid atherosclerosis and serum cholesterol levels in eastern Finland.
    Salonen R; Seppänen K; Rauramaa R; Salonen JT
    Arteriosclerosis; 1988; 8(6):788-92. PubMed ID: 3196222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intermediate-density lipoproteins and progression of carotid arterial wall intima-media thickness.
    Hodis HN; Mack WJ; Dunn M; Liu C; Liu C; Selzer RH; Krauss RM
    Circulation; 1997 Apr; 95(8):2022-6. PubMed ID: 9133510
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Carotid atherosclerosis in renal transplant recipients: relationships with cardiovascular risk factors and plasma lipoproteins.
    Barbagallo CM; Pinto A; Gallo S; Parrinello G; Caputo F; Sparacino V; Cefalù AB; Novo S; Licata G; Notarbartolo A; Averna MR
    Transplantation; 1999 Feb; 67(3):366-71. PubMed ID: 10030280
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of cocaine use on protease inhibitor-associated dyslipidemia in HIV-infected adults.
    Li J; Lai H; Chen S; Lai S
    Int J STD AIDS; 2018 Jul; 29(8):781-789. PubMed ID: 29471762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of human immunodeficiency virus-1 protease inhibitors is associated with atherogenic lipoprotein changes and endothelial dysfunction.
    Stein JH; Klein MA; Bellehumeur JL; McBride PE; Wiebe DA; Otvos JD; Sosman JM
    Circulation; 2001 Jul; 104(3):257-62. PubMed ID: 11457741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.